Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis.
about
Role of Inhaled Nitric Oxide in the Management of Severe Acute Respiratory Distress SyndromeThe standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemiaIdentifying low-value clinical practices in critical care medicine: protocol for a scoping reviewAcute respiratory distress syndrome following cardiovascular surgery: current concepts and novel therapeutic approachesClinical Practice Guideline of Acute Respiratory Distress SyndromePathophysiological Mechanisms in Gaseous Therapies for Severe MalariaInhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trialsLong-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*The role of inhaled prostacyclin in treating acute respiratory distress syndrome.The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysisInhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study.Lugrandoside attenuates LPS-induced acute respiratory distress syndrome by anti-inflammation and anti-apoptosis in mice.Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases.Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome.Adjuvants to mechanical ventilation for acute respiratory distress syndrome.Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena?Inhibition of TNF Receptor p55 By a Domain Antibody Attenuates the Initial Phase of Acid-Induced Lung Injury in Mice.Current Concepts of ARDS: A Narrative Review.Capabilities of a mobile extracorporeal membrane oxygenation service for severe respiratory failure delivered by intensive care specialists.Inhalation therapies in acute respiratory distress syndrome.A 10-year retrospective study of interhospital patient transport using inhaled nitric oxide in Norway.Preventing ventilator-induced lung injury-what does the evidence say?Inhaled nitric oxide and acute kidney injury: new insights from observational data.Fifty Years of Research in ARDS. Gas Exchange in Acute Respiratory Distress Syndrome.Pharmacological treatment versus acute lung injury/acute respiratory distress syndrome - reflections from the clinical perspective and yacht racing (and more).Association of Response to Inhaled Nitric Oxide and Duration of Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome.No redistribution of lung blood flow by inhaled nitric oxide in endotoxemic piglets pretreated with an endothelin receptor antagonist.Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure.Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury.
P2860
Q26741096-96F519D6-8E7C-4FB9-B6B0-F2CC1226EB11Q26753063-296943EB-DE0E-490C-AB02-A34D9B9B1852Q26778161-35B3416E-ACD2-4945-8E97-5F384500879EQ27693319-44A37CBE-CCC0-4D2E-AF8E-1F4FB9B2BAAFQ28074353-4E41F0A5-3BBF-45FC-B918-0B9F51CBAF67Q28080030-2B28EFB3-CB25-4DEB-A8EC-7D3EE2BB8F01Q28087535-058C3FB5-4351-48D4-98C4-DE2A2B71A7ADQ33769396-E972D6B4-046B-493F-97CA-3C0AA627CAFBQ34490411-F143FA6F-B253-4596-BFDF-F22471B497ECQ35572093-8C194949-BF64-460A-8AFE-DFD6FD608560Q37460471-4C8639EF-6483-4BAF-8A5D-00950AB0A7C7Q37553820-5E53CE66-F66D-4A79-B35F-26724986EA8EQ38247234-3C8BF1BF-8191-4FF1-B2BA-D9541483C7C3Q38621788-986F678C-BAD1-41A6-89F0-A72064D73913Q38775825-FF39EB83-E298-48D5-9A56-6F8B4550228BQ38778992-B59F5097-D339-446C-813E-E6664959AC6CQ38792121-76191AFD-CDB1-41C0-98AF-8B401F5BB37BQ38842183-DA5ECE97-05A8-4975-BECF-340D995B9221Q38938464-09686523-1D25-4F8C-8901-8683F29F2955Q39063062-ED01996A-6E4F-481B-A8CA-F274EE10A143Q41104479-7455FDCE-F948-4ABE-8808-E0F810189F50Q41190745-68781DCD-AD5D-4C9F-A06C-F387C19CD41EQ41203062-1FBB236F-61DA-4333-93AE-AED3DDA3F69AQ42357391-400C05BE-A7E6-4B53-B61F-094197478743Q42368908-C6B94F2D-80E0-49F4-98EA-85869E571729Q47307536-67C032F3-A8D8-4E59-9B3D-B5B78D76E20DQ47424596-13C575DA-367C-4DB1-B9F6-12B2C5F26E4AQ47724485-CAE27EC5-8998-4F63-9407-AAD3D8697F84Q51671344-AA53A843-E194-4C04-A5BF-B05BD616E475Q54737397-99E9244E-9180-4980-BE0A-E246FA9A323BQ55022988-E11138E8-EE7E-4023-B614-C1209BF4D8FE
P2860
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@ast
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@en
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@nl
type
label
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@ast
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@en
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@nl
prefLabel
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@ast
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@en
Inhaled nitric oxide does not ...... atic review and meta-analysis.
@nl
P2093
P1476
Inhaled nitric oxide does not ...... matic review and meta-analysis
@en
P2093
Benoit Vallet
Didier Payen
Herwig Gerlach
Kwang Joo Park
Neill K J Adhikari
R Phillip Dellinger
Sangeeta Mehta
Stefan Lundin
P304
P356
10.1097/CCM.0B013E3182A27909
P407
P577
2014-02-01T00:00:00Z